nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM3—Carbachol—glaucoma	0.16	0.194	CbGbCtD
Methylscopolamine bromide—CHRM3—Pilocarpine—glaucoma	0.149	0.18	CbGbCtD
Methylscopolamine bromide—CHRM1—Carbachol—glaucoma	0.139	0.169	CbGbCtD
Methylscopolamine bromide—CHRM1—Pilocarpine—glaucoma	0.129	0.157	CbGbCtD
Methylscopolamine bromide—CHRM2—Carbachol—glaucoma	0.128	0.156	CbGbCtD
Methylscopolamine bromide—CHRM2—Pilocarpine—glaucoma	0.119	0.145	CbGbCtD
Methylscopolamine bromide—Mydriasis—Dipivefrin—glaucoma	0.00775	0.0441	CcSEcCtD
Methylscopolamine bromide—Mydriasis—Apraclonidine—glaucoma	0.00283	0.0161	CcSEcCtD
Methylscopolamine bromide—Accommodation disorder—Clonidine—glaucoma	0.00243	0.0138	CcSEcCtD
Methylscopolamine bromide—Mydriasis—Travoprost—glaucoma	0.00231	0.0131	CcSEcCtD
Methylscopolamine bromide—Ageusia—Brinzolamide—glaucoma	0.00224	0.0128	CcSEcCtD
Methylscopolamine bromide—Ageusia—Pilocarpine—glaucoma	0.00216	0.0123	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Dipivefrin—glaucoma	0.00215	0.0123	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Echothiophate—glaucoma	0.00214	0.0121	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Diclofenamide—glaucoma	0.00177	0.0101	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Levobunolol—glaucoma	0.00176	0.01	CcSEcCtD
Methylscopolamine bromide—Vomiting—Physostigmine—glaucoma	0.00165	0.00939	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Methazolamide—glaucoma	0.00163	0.00928	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Dipivefrin—glaucoma	0.00163	0.00925	CcSEcCtD
Methylscopolamine bromide—Nausea—Physostigmine—glaucoma	0.00154	0.00877	CcSEcCtD
Methylscopolamine bromide—Ageusia—Betaxolol—glaucoma	0.0015	0.00853	CcSEcCtD
Methylscopolamine bromide—Tension—Metipranolol—glaucoma	0.00149	0.00849	CcSEcCtD
Methylscopolamine bromide—Nervousness—Metipranolol—glaucoma	0.00148	0.0084	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Metipranolol—glaucoma	0.00143	0.00815	CcSEcCtD
Methylscopolamine bromide—Tension—Diclofenamide—glaucoma	0.00136	0.00773	CcSEcCtD
Methylscopolamine bromide—Nervousness—Diclofenamide—glaucoma	0.00134	0.00765	CcSEcCtD
Methylscopolamine bromide—Palpitations—Metipranolol—glaucoma	0.00134	0.00764	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Carteolol—glaucoma	0.00133	0.00755	CcSEcCtD
Methylscopolamine bromide—Palpitations—Carteolol—glaucoma	0.00124	0.00708	CcSEcCtD
Methylscopolamine bromide—Palpitations—Levobunolol—glaucoma	0.00118	0.00669	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Latanoprost—glaucoma	0.00116	0.00662	CcSEcCtD
Methylscopolamine bromide—Confusional state—Diclofenamide—glaucoma	0.00114	0.00648	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Acetazolamide—glaucoma	0.00113	0.00642	CcSEcCtD
Methylscopolamine bromide—Somnolence—Metipranolol—glaucoma	0.0011	0.00627	CcSEcCtD
Methylscopolamine bromide—Confusional state—Levobunolol—glaucoma	0.00109	0.00623	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Brimonidine—glaucoma	0.00108	0.00616	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Dorzolamide—glaucoma	0.00107	0.00608	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Brinzolamide—glaucoma	0.00105	0.00598	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methazolamide—glaucoma	0.00105	0.00597	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methazolamide—glaucoma	0.00104	0.00592	CcSEcCtD
Methylscopolamine bromide—Insomnia—Carteolol—glaucoma	0.00104	0.00591	CcSEcCtD
Methylscopolamine bromide—Somnolence—Diclofenamide—glaucoma	0.001	0.00571	CcSEcCtD
Methylscopolamine bromide—Tension—Apraclonidine—glaucoma	0.000968	0.00551	CcSEcCtD
Methylscopolamine bromide—Constipation—Diclofenamide—glaucoma	0.000966	0.0055	CcSEcCtD
Methylscopolamine bromide—Nervousness—Apraclonidine—glaucoma	0.000958	0.00545	CcSEcCtD
Methylscopolamine bromide—Tension—Bimatoprost—glaucoma	0.000938	0.00534	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Diclofenamide—glaucoma	0.000931	0.0053	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Apraclonidine—glaucoma	0.000929	0.00529	CcSEcCtD
Methylscopolamine bromide—Nervousness—Bimatoprost—glaucoma	0.000929	0.00528	CcSEcCtD
Methylscopolamine bromide—Somnolence—Methazolamide—glaucoma	0.000925	0.00526	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Metipranolol—glaucoma	0.000914	0.0052	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Bimatoprost—glaucoma	0.000901	0.00513	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Levobunolol—glaucoma	0.000895	0.00509	CcSEcCtD
Methylscopolamine bromide—Asthenia—Metipranolol—glaucoma	0.00089	0.00506	CcSEcCtD
Methylscopolamine bromide—Palpitations—Apraclonidine—glaucoma	0.000871	0.00496	CcSEcCtD
Methylscopolamine bromide—Urticaria—Levobunolol—glaucoma	0.000862	0.00491	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methazolamide—glaucoma	0.000857	0.00488	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Carteolol—glaucoma	0.000846	0.00482	CcSEcCtD
Methylscopolamine bromide—Palpitations—Bimatoprost—glaucoma	0.000845	0.00481	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methazolamide—glaucoma	0.000826	0.0047	CcSEcCtD
Methylscopolamine bromide—Asthenia—Carteolol—glaucoma	0.000824	0.00469	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Apraclonidine—glaucoma	0.000821	0.00467	CcSEcCtD
Methylscopolamine bromide—Dizziness—Metipranolol—glaucoma	0.00082	0.00467	CcSEcCtD
Methylscopolamine bromide—Asthenia—Diclofenamide—glaucoma	0.00081	0.00461	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Clonidine—glaucoma	0.000806	0.00459	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Levobunolol—glaucoma	0.0008	0.00455	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Brimonidine—glaucoma	0.000798	0.00454	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Bimatoprost—glaucoma	0.000796	0.00453	CcSEcCtD
Methylscopolamine bromide—Tension—Dorzolamide—glaucoma	0.000793	0.00451	CcSEcCtD
Methylscopolamine bromide—Nervousness—Dorzolamide—glaucoma	0.000785	0.00447	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Clonidine—glaucoma	0.000781	0.00444	CcSEcCtD
Methylscopolamine bromide—Tension—Brinzolamide—glaucoma	0.00078	0.00444	CcSEcCtD
Methylscopolamine bromide—Asthenia—Levobunolol—glaucoma	0.000779	0.00443	CcSEcCtD
Methylscopolamine bromide—Headache—Metipranolol—glaucoma	0.000777	0.00442	CcSEcCtD
Methylscopolamine bromide—Nervousness—Brinzolamide—glaucoma	0.000772	0.00439	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Dorzolamide—glaucoma	0.000762	0.00434	CcSEcCtD
Methylscopolamine bromide—Dizziness—Carteolol—glaucoma	0.00076	0.00432	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Travoprost—glaucoma	0.000759	0.00432	CcSEcCtD
Methylscopolamine bromide—Tension—Pilocarpine—glaucoma	0.00075	0.00427	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Brinzolamide—glaucoma	0.000749	0.00426	CcSEcCtD
Methylscopolamine bromide—Palpitations—Brimonidine—glaucoma	0.000748	0.00426	CcSEcCtD
Methylscopolamine bromide—Dizziness—Diclofenamide—glaucoma	0.000747	0.00425	CcSEcCtD
Methylscopolamine bromide—Asthenia—Methazolamide—glaucoma	0.000746	0.00425	CcSEcCtD
Methylscopolamine bromide—Nervousness—Pilocarpine—glaucoma	0.000742	0.00422	CcSEcCtD
Methylscopolamine bromide—Nausea—Metipranolol—glaucoma	0.000737	0.00419	CcSEcCtD
Methylscopolamine bromide—Dizziness—Carbachol—glaucoma	0.000729	0.00415	CcSEcCtD
Methylscopolamine bromide—Insomnia—Apraclonidine—glaucoma	0.000728	0.00414	CcSEcCtD
Methylscopolamine bromide—Confusional state—Acetazolamide—glaucoma	0.000726	0.00413	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Pilocarpine—glaucoma	0.00072	0.0041	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Acetazolamide—glaucoma	0.00072	0.0041	CcSEcCtD
Methylscopolamine bromide—Headache—Carteolol—glaucoma	0.00072	0.0041	CcSEcCtD
Methylscopolamine bromide—Vomiting—Diclofenamide—glaucoma	0.000718	0.00409	CcSEcCtD
Methylscopolamine bromide—Dizziness—Levobunolol—glaucoma	0.000718	0.00409	CcSEcCtD
Methylscopolamine bromide—Somnolence—Apraclonidine—glaucoma	0.000715	0.00407	CcSEcCtD
Methylscopolamine bromide—Palpitations—Dorzolamide—glaucoma	0.000714	0.00407	CcSEcCtD
Methylscopolamine bromide—Palpitations—Travoprost—glaucoma	0.000711	0.00405	CcSEcCtD
Methylscopolamine bromide—Headache—Diclofenamide—glaucoma	0.000708	0.00403	CcSEcCtD
Methylscopolamine bromide—Insomnia—Bimatoprost—glaucoma	0.000706	0.00402	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Brimonidine—glaucoma	0.000705	0.00401	CcSEcCtD
Methylscopolamine bromide—Palpitations—Brinzolamide—glaucoma	0.000702	0.004	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Betaxolol—glaucoma	0.000702	0.004	CcSEcCtD
Methylscopolamine bromide—Vomiting—Carbachol—glaucoma	0.000701	0.00399	CcSEcCtD
Methylscopolamine bromide—Somnolence—Bimatoprost—glaucoma	0.000694	0.00395	CcSEcCtD
Methylscopolamine bromide—Headache—Carbachol—glaucoma	0.000691	0.00393	CcSEcCtD
Methylscopolamine bromide—Constipation—Apraclonidine—glaucoma	0.000688	0.00392	CcSEcCtD
Methylscopolamine bromide—Nausea—Carteolol—glaucoma	0.000682	0.00388	CcSEcCtD
Methylscopolamine bromide—Headache—Levobunolol—glaucoma	0.00068	0.00387	CcSEcCtD
Methylscopolamine bromide—Palpitations—Pilocarpine—glaucoma	0.000675	0.00384	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Brimonidine—glaucoma	0.000674	0.00384	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Dorzolamide—glaucoma	0.000673	0.00383	CcSEcCtD
Methylscopolamine bromide—Nausea—Diclofenamide—glaucoma	0.000671	0.00382	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Travoprost—glaucoma	0.00067	0.00381	CcSEcCtD
Methylscopolamine bromide—Dizziness—Latanoprost—glaucoma	0.000666	0.00379	CcSEcCtD
Methylscopolamine bromide—Confusional state—Dorzolamide—glaucoma	0.000665	0.00379	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Apraclonidine—glaucoma	0.000663	0.00377	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Brinzolamide—glaucoma	0.000662	0.00377	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methazolamide—glaucoma	0.000661	0.00376	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Dorzolamide—glaucoma	0.00066	0.00375	CcSEcCtD
Methylscopolamine bromide—Nausea—Carbachol—glaucoma	0.000655	0.00373	CcSEcCtD
Methylscopolamine bromide—Headache—Methazolamide—glaucoma	0.000652	0.00371	CcSEcCtD
Methylscopolamine bromide—Nausea—Levobunolol—glaucoma	0.000645	0.00367	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Travoprost—glaucoma	0.000641	0.00365	CcSEcCtD
Methylscopolamine bromide—Somnolence—Acetazolamide—glaucoma	0.00064	0.00364	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Brinzolamide—glaucoma	0.000633	0.0036	CcSEcCtD
Methylscopolamine bromide—Headache—Latanoprost—glaucoma	0.000631	0.00359	CcSEcCtD
Methylscopolamine bromide—Confusional state—Pilocarpine—glaucoma	0.000629	0.00358	CcSEcCtD
Methylscopolamine bromide—Insomnia—Brimonidine—glaucoma	0.000625	0.00356	CcSEcCtD
Methylscopolamine bromide—Nausea—Methazolamide—glaucoma	0.000618	0.00352	CcSEcCtD
Methylscopolamine bromide—Somnolence—Brimonidine—glaucoma	0.000614	0.0035	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Pilocarpine—glaucoma	0.000609	0.00346	CcSEcCtD
Methylscopolamine bromide—Tension—Clonidine—glaucoma	0.000599	0.00341	CcSEcCtD
Methylscopolamine bromide—Insomnia—Dorzolamide—glaucoma	0.000597	0.0034	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Acetazolamide—glaucoma	0.000593	0.00338	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Apraclonidine—glaucoma	0.000593	0.00337	CcSEcCtD
Methylscopolamine bromide—Nervousness—Clonidine—glaucoma	0.000593	0.00337	CcSEcCtD
Methylscopolamine bromide—Insomnia—Brinzolamide—glaucoma	0.000587	0.00334	CcSEcCtD
Methylscopolamine bromide—Somnolence—Dorzolamide—glaucoma	0.000587	0.00334	CcSEcCtD
Methylscopolamine bromide—Asthenia—Apraclonidine—glaucoma	0.000577	0.00329	CcSEcCtD
Methylscopolamine bromide—Somnolence—Brinzolamide—glaucoma	0.000577	0.00328	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Clonidine—glaucoma	0.000575	0.00327	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Timolol—glaucoma	0.000574	0.00326	CcSEcCtD
Methylscopolamine bromide—Urticaria—Acetazolamide—glaucoma	0.000572	0.00325	CcSEcCtD
Methylscopolamine bromide—Insomnia—Pilocarpine—glaucoma	0.000564	0.00321	CcSEcCtD
Methylscopolamine bromide—Constipation—Travoprost—glaucoma	0.000562	0.0032	CcSEcCtD
Methylscopolamine bromide—Asthenia—Bimatoprost—glaucoma	0.00056	0.00319	CcSEcCtD
Methylscopolamine bromide—Somnolence—Pilocarpine—glaucoma	0.000554	0.00315	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Dorzolamide—glaucoma	0.000544	0.00309	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Travoprost—glaucoma	0.000541	0.00308	CcSEcCtD
Methylscopolamine bromide—Palpitations—Clonidine—glaucoma	0.000539	0.00307	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Brinzolamide—glaucoma	0.000535	0.00304	CcSEcCtD
Methylscopolamine bromide—Constipation—Pilocarpine—glaucoma	0.000533	0.00303	CcSEcCtD
Methylscopolamine bromide—Dizziness—Apraclonidine—glaucoma	0.000532	0.00303	CcSEcCtD
Methylscopolamine bromide—Urticaria—Dorzolamide—glaucoma	0.000524	0.00298	CcSEcCtD
Methylscopolamine bromide—Tension—Betaxolol—glaucoma	0.000521	0.00297	CcSEcCtD
Methylscopolamine bromide—Asthenia—Acetazolamide—glaucoma	0.000516	0.00294	CcSEcCtD
Methylscopolamine bromide—Dizziness—Bimatoprost—glaucoma	0.000516	0.00294	CcSEcCtD
Methylscopolamine bromide—Nervousness—Betaxolol—glaucoma	0.000516	0.00294	CcSEcCtD
Methylscopolamine bromide—Urticaria—Brinzolamide—glaucoma	0.000515	0.00293	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Pilocarpine—glaucoma	0.000514	0.00292	CcSEcCtD
Methylscopolamine bromide—Vomiting—Apraclonidine—glaucoma	0.000512	0.00291	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Brimonidine—glaucoma	0.000509	0.0029	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Clonidine—glaucoma	0.000508	0.00289	CcSEcCtD
Methylscopolamine bromide—Headache—Apraclonidine—glaucoma	0.000504	0.00287	CcSEcCtD
Methylscopolamine bromide—Confusional state—Clonidine—glaucoma	0.000502	0.00286	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Betaxolol—glaucoma	0.000501	0.00285	CcSEcCtD
Methylscopolamine bromide—Asthenia—Brimonidine—glaucoma	0.000496	0.00282	CcSEcCtD
Methylscopolamine bromide—Headache—Bimatoprost—glaucoma	0.000489	0.00278	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Dorzolamide—glaucoma	0.000486	0.00277	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Clonidine—glaucoma	0.000486	0.00277	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Travoprost—glaucoma	0.000484	0.00275	CcSEcCtD
Methylscopolamine bromide—Nausea—Apraclonidine—glaucoma	0.000478	0.00272	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Brinzolamide—glaucoma	0.000478	0.00272	CcSEcCtD
Methylscopolamine bromide—Dizziness—Acetazolamide—glaucoma	0.000476	0.00271	CcSEcCtD
Methylscopolamine bromide—Asthenia—Dorzolamide—glaucoma	0.000473	0.00269	CcSEcCtD
Methylscopolamine bromide—Asthenia—Travoprost—glaucoma	0.000471	0.00268	CcSEcCtD
Methylscopolamine bromide—Palpitations—Betaxolol—glaucoma	0.000469	0.00267	CcSEcCtD
Methylscopolamine bromide—Asthenia—Brinzolamide—glaucoma	0.000465	0.00265	CcSEcCtD
Methylscopolamine bromide—Nausea—Bimatoprost—glaucoma	0.000463	0.00264	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Pilocarpine—glaucoma	0.000459	0.00261	CcSEcCtD
Methylscopolamine bromide—Vomiting—Acetazolamide—glaucoma	0.000458	0.0026	CcSEcCtD
Methylscopolamine bromide—Dizziness—Brimonidine—glaucoma	0.000457	0.0026	CcSEcCtD
Methylscopolamine bromide—Headache—Acetazolamide—glaucoma	0.000451	0.00257	CcSEcCtD
Methylscopolamine bromide—Insomnia—Clonidine—glaucoma	0.00045	0.00256	CcSEcCtD
Methylscopolamine bromide—Asthenia—Pilocarpine—glaucoma	0.000447	0.00255	CcSEcCtD
Methylscopolamine bromide—Somnolence—Clonidine—glaucoma	0.000443	0.00252	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Betaxolol—glaucoma	0.000442	0.00252	CcSEcCtD
Methylscopolamine bromide—Confusional state—Betaxolol—glaucoma	0.000437	0.00249	CcSEcCtD
Methylscopolamine bromide—Dizziness—Dorzolamide—glaucoma	0.000436	0.00248	CcSEcCtD
Methylscopolamine bromide—Dizziness—Travoprost—glaucoma	0.000434	0.00247	CcSEcCtD
Methylscopolamine bromide—Headache—Brimonidine—glaucoma	0.000433	0.00246	CcSEcCtD
Methylscopolamine bromide—Dizziness—Brinzolamide—glaucoma	0.000429	0.00244	CcSEcCtD
Methylscopolamine bromide—Nausea—Acetazolamide—glaucoma	0.000428	0.00243	CcSEcCtD
Methylscopolamine bromide—Tension—Timolol—glaucoma	0.000426	0.00242	CcSEcCtD
Methylscopolamine bromide—Constipation—Clonidine—glaucoma	0.000426	0.00242	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Betaxolol—glaucoma	0.000423	0.00241	CcSEcCtD
Methylscopolamine bromide—Nervousness—Timolol—glaucoma	0.000421	0.0024	CcSEcCtD
Methylscopolamine bromide—Vomiting—Dorzolamide—glaucoma	0.00042	0.00239	CcSEcCtD
Methylscopolamine bromide—Headache—Dorzolamide—glaucoma	0.000413	0.00235	CcSEcCtD
Methylscopolamine bromide—Vomiting—Brinzolamide—glaucoma	0.000412	0.00235	CcSEcCtD
Methylscopolamine bromide—Dizziness—Pilocarpine—glaucoma	0.000412	0.00235	CcSEcCtD
Methylscopolamine bromide—Headache—Travoprost—glaucoma	0.000412	0.00234	CcSEcCtD
Methylscopolamine bromide—Nausea—Brimonidine—glaucoma	0.00041	0.00234	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Clonidine—glaucoma	0.00041	0.00233	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Timolol—glaucoma	0.000409	0.00233	CcSEcCtD
Methylscopolamine bromide—Headache—Brinzolamide—glaucoma	0.000406	0.00231	CcSEcCtD
Methylscopolamine bromide—Vomiting—Pilocarpine—glaucoma	0.000396	0.00226	CcSEcCtD
Methylscopolamine bromide—Urticaria—Clonidine—glaucoma	0.000396	0.00225	CcSEcCtD
Methylscopolamine bromide—Insomnia—Betaxolol—glaucoma	0.000392	0.00223	CcSEcCtD
Methylscopolamine bromide—Nausea—Dorzolamide—glaucoma	0.000392	0.00223	CcSEcCtD
Methylscopolamine bromide—Headache—Pilocarpine—glaucoma	0.000391	0.00222	CcSEcCtD
Methylscopolamine bromide—Nausea—Travoprost—glaucoma	0.00039	0.00222	CcSEcCtD
Methylscopolamine bromide—Nausea—Brinzolamide—glaucoma	0.000385	0.00219	CcSEcCtD
Methylscopolamine bromide—Palpitations—Timolol—glaucoma	0.000383	0.00218	CcSEcCtD
Methylscopolamine bromide—Constipation—Betaxolol—glaucoma	0.000371	0.00211	CcSEcCtD
Methylscopolamine bromide—Nausea—Pilocarpine—glaucoma	0.00037	0.00211	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Clonidine—glaucoma	0.000367	0.00209	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Timolol—glaucoma	0.000361	0.00206	CcSEcCtD
Methylscopolamine bromide—Asthenia—Clonidine—glaucoma	0.000357	0.00203	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Betaxolol—glaucoma	0.000357	0.00203	CcSEcCtD
Methylscopolamine bromide—Confusional state—Timolol—glaucoma	0.000357	0.00203	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Timolol—glaucoma	0.000354	0.00202	CcSEcCtD
Methylscopolamine bromide—Urticaria—Betaxolol—glaucoma	0.000344	0.00196	CcSEcCtD
Methylscopolamine bromide—Dizziness—Clonidine—glaucoma	0.000329	0.00187	CcSEcCtD
Methylscopolamine bromide—Insomnia—Timolol—glaucoma	0.00032	0.00182	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Betaxolol—glaucoma	0.000319	0.00182	CcSEcCtD
Methylscopolamine bromide—Vomiting—Clonidine—glaucoma	0.000317	0.0018	CcSEcCtD
Methylscopolamine bromide—Somnolence—Timolol—glaucoma	0.000315	0.00179	CcSEcCtD
Methylscopolamine bromide—Headache—Clonidine—glaucoma	0.000312	0.00178	CcSEcCtD
Methylscopolamine bromide—Asthenia—Betaxolol—glaucoma	0.000311	0.00177	CcSEcCtD
Methylscopolamine bromide—Nausea—Clonidine—glaucoma	0.000296	0.00168	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Timolol—glaucoma	0.000292	0.00166	CcSEcCtD
Methylscopolamine bromide—Dizziness—Betaxolol—glaucoma	0.000287	0.00163	CcSEcCtD
Methylscopolamine bromide—Urticaria—Timolol—glaucoma	0.000281	0.0016	CcSEcCtD
Methylscopolamine bromide—Vomiting—Betaxolol—glaucoma	0.000276	0.00157	CcSEcCtD
Methylscopolamine bromide—Headache—Betaxolol—glaucoma	0.000272	0.00155	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Timolol—glaucoma	0.000261	0.00148	CcSEcCtD
Methylscopolamine bromide—Nausea—Betaxolol—glaucoma	0.000257	0.00147	CcSEcCtD
Methylscopolamine bromide—Asthenia—Timolol—glaucoma	0.000254	0.00145	CcSEcCtD
Methylscopolamine bromide—Dizziness—Timolol—glaucoma	0.000234	0.00133	CcSEcCtD
Methylscopolamine bromide—Vomiting—Timolol—glaucoma	0.000225	0.00128	CcSEcCtD
Methylscopolamine bromide—Headache—Timolol—glaucoma	0.000222	0.00126	CcSEcCtD
Methylscopolamine bromide—Nausea—Timolol—glaucoma	0.00021	0.0012	CcSEcCtD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—ATOH7—glaucoma	2.41e-05	0.0327	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—LMX1B—glaucoma	1.88e-05	0.0255	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Other—PTGFR—glaucoma	1.62e-05	0.022	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Other—PTGFR—glaucoma	1.61e-05	0.0218	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—OPN4—glaucoma	1.44e-05	0.0196	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—PTGFR—glaucoma	1.3e-05	0.0177	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	1.29e-05	0.0175	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Regulation of Actin Cytoskeleton—MYLK—glaucoma	1.29e-05	0.0175	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	1.22e-05	0.0166	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	1.16e-05	0.0158	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	1.12e-05	0.0152	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—OPN4—glaucoma	1.02e-05	0.0138	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—OPN4—glaucoma	1.01e-05	0.0138	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.01e-05	0.0136	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—OPN4—glaucoma	9.6e-06	0.013	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	9.57e-06	0.013	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—PTGFR—glaucoma	9.16e-06	0.0124	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—PTGFR—glaucoma	9.13e-06	0.0124	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	9.1e-06	0.0123	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	9.07e-06	0.0123	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Regulation of Actin Cytoskeleton—MYLK—glaucoma	9.07e-06	0.0123	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of Actin Cytoskeleton—MYLK—glaucoma	9.04e-06	0.0123	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Regulation of Actin Cytoskeleton—MYLK—glaucoma	8.95e-06	0.0121	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	8.61e-06	0.0117	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	8.6e-06	0.0117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	8.57e-06	0.0116	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	8.49e-06	0.0115	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	8.19e-06	0.0111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Other—SMO—glaucoma	8.19e-06	0.0111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	8.16e-06	0.0111	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Other—SMO—glaucoma	8.11e-06	0.011	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	7.86e-06	0.0107	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	7.84e-06	0.0106	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	7.76e-06	0.0105	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—OPN4—glaucoma	7.29e-06	0.00989	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	7.08e-06	0.00961	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	7.06e-06	0.00958	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	6.99e-06	0.00948	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	6.74e-06	0.00914	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—HDAC9—glaucoma	6.73e-06	0.00914	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	6.71e-06	0.00911	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	6.65e-06	0.00903	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—PTGFR—glaucoma	6.56e-06	0.0089	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	6.06e-06	0.00823	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	6.05e-06	0.00821	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	5.99e-06	0.00813	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—OPN4—glaucoma	5.13e-06	0.00696	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—OPN4—glaucoma	5.11e-06	0.00694	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—OPN4—glaucoma	5.06e-06	0.00687	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—NTRK2—glaucoma	4.82e-06	0.00654	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—PTGFR—glaucoma	4.62e-06	0.00627	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—PTGFR—glaucoma	4.6e-06	0.00625	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—PTGFR—glaucoma	4.56e-06	0.00619	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—EDN1—glaucoma	4.32e-06	0.00587	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—OPN4—glaucoma	4.12e-06	0.00559	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.98e-06	0.0054	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.87e-06	0.00525	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—OPN4—glaucoma	3.74e-06	0.00507	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PTGFR—glaucoma	3.71e-06	0.00503	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—BDNF—glaucoma	3.6e-06	0.00488	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NARFL—glaucoma	3.53e-06	0.00479	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CA5A—glaucoma	3.53e-06	0.00479	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL1A—glaucoma	3.45e-06	0.00469	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—NGFR—glaucoma	3.42e-06	0.00464	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PTGFR—glaucoma	3.37e-06	0.00457	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—SMO—glaucoma	3.31e-06	0.00449	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	3.25e-06	0.00441	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—NGF—glaucoma	3.19e-06	0.00433	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LRP12—glaucoma	3.19e-06	0.00432	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—NR3C1—glaucoma	3.18e-06	0.00431	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	3.04e-06	0.00413	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—EDN1—glaucoma	3.03e-06	0.00412	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—OPN4—glaucoma	2.9e-06	0.00393	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—OPN4—glaucoma	2.89e-06	0.00392	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.86e-06	0.00389	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—OPN4—glaucoma	2.86e-06	0.00388	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.8e-06	0.0038	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.79e-06	0.00379	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.76e-06	0.00375	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.72e-06	0.0037	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.71e-06	0.00368	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—OPN4—glaucoma	2.63e-06	0.00357	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—OPN4—glaucoma	2.62e-06	0.00356	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	2.61e-06	0.00354	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PTGFR—glaucoma	2.6e-06	0.00353	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—OPN4—glaucoma	2.6e-06	0.00353	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PTGFR—glaucoma	2.58e-06	0.0035	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—FAS—glaucoma	2.55e-06	0.00346	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.5e-06	0.0034	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PTGFR—glaucoma	2.37e-06	0.00322	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PTGFR—glaucoma	2.36e-06	0.00321	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PTGFR—glaucoma	2.34e-06	0.00318	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—SMO—glaucoma	2.33e-06	0.00316	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—SMO—glaucoma	2.32e-06	0.00315	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—SMO—glaucoma	2.3e-06	0.00312	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LRP12—glaucoma	2.24e-06	0.00305	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LRP12—glaucoma	2.24e-06	0.00304	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LRP12—glaucoma	2.21e-06	0.00301	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—OPN4—glaucoma	2.21e-06	0.003	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—C3—glaucoma	2.19e-06	0.00297	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—EDN1—glaucoma	2.18e-06	0.00296	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HEYL—glaucoma	2.05e-06	0.00279	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.02e-06	0.00274	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.01e-06	0.00273	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.99e-06	0.0027	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTGFR—glaucoma	1.99e-06	0.0027	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—C3—glaucoma	1.91e-06	0.00259	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.76e-06	0.00239	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.76e-06	0.00238	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.74e-06	0.00236	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CA1—glaucoma	1.72e-06	0.00234	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—SMO—glaucoma	1.7e-06	0.0023	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CTSA—glaucoma	1.67e-06	0.00227	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CA2—glaucoma	1.58e-06	0.00214	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RPTOR—glaucoma	1.56e-06	0.00211	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—OPN4—glaucoma	1.56e-06	0.00211	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—OPN4—glaucoma	1.55e-06	0.0021	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—EDN1—glaucoma	1.54e-06	0.00208	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—OPN4—glaucoma	1.54e-06	0.00208	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—EDN1—glaucoma	1.53e-06	0.00208	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.53e-06	0.00207	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—EDN1—glaucoma	1.52e-06	0.00206	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NCK2—glaucoma	1.51e-06	0.00205	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HEYL—glaucoma	1.45e-06	0.00196	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HEYL—glaucoma	1.44e-06	0.00196	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HEYL—glaucoma	1.43e-06	0.00194	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTGFR—glaucoma	1.4e-06	0.0019	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTGFR—glaucoma	1.4e-06	0.00189	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTGFR—glaucoma	1.38e-06	0.00188	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—C3—glaucoma	1.34e-06	0.00182	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—C3—glaucoma	1.34e-06	0.00181	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—C3—glaucoma	1.32e-06	0.0018	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	1.31e-06	0.00177	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HDAC9—glaucoma	1.28e-06	0.00174	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—EDN1—glaucoma	1.23e-06	0.00167	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—SMO—glaucoma	1.2e-06	0.00162	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—SMO—glaucoma	1.19e-06	0.00162	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—SMO—glaucoma	1.18e-06	0.0016	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—EDN1—glaucoma	1.12e-06	0.00152	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—TXN—glaucoma	1.11e-06	0.00151	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RPTOR—glaucoma	1.1e-06	0.00149	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RPTOR—glaucoma	1.09e-06	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RPTOR—glaucoma	1.08e-06	0.00147	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—C3—glaucoma	1.08e-06	0.00146	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NCK2—glaucoma	1.06e-06	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NCK2—glaucoma	1.06e-06	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NCK2—glaucoma	1.05e-06	0.00142	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SMO—glaucoma	1e-06	0.00136	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—C3—glaucoma	9.78e-07	0.00133	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—TP53—glaucoma	9.53e-07	0.00129	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NTRK2—glaucoma	9.17e-07	0.00124	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HDAC9—glaucoma	9.02e-07	0.00122	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HDAC9—glaucoma	8.99e-07	0.00122	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HDAC9—glaucoma	8.91e-07	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—EDN1—glaucoma	8.68e-07	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—EDN1—glaucoma	8.65e-07	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GSTT1—glaucoma	8.61e-07	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—EDN1—glaucoma	8.57e-07	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—EDN1—glaucoma	7.88e-07	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NGFR—glaucoma	7.87e-07	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—EDN1—glaucoma	7.85e-07	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—EDN1—glaucoma	7.78e-07	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—C3—glaucoma	7.58e-07	0.00103	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—C3—glaucoma	7.56e-07	0.00103	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—C3—glaucoma	7.48e-07	0.00102	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NTRK1—glaucoma	7.48e-07	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SMO—glaucoma	7.06e-07	0.000958	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SMO—glaucoma	7.04e-07	0.000955	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SMO—glaucoma	6.97e-07	0.000946	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CDKN2B—glaucoma	6.89e-07	0.000935	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—C3—glaucoma	6.88e-07	0.000934	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—C3—glaucoma	6.86e-07	0.000931	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CYP1B1—glaucoma	6.86e-07	0.000931	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ABCA1—glaucoma	6.86e-07	0.000931	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—C3—glaucoma	6.79e-07	0.000922	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EDN1—glaucoma	6.61e-07	0.000897	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NTRK2—glaucoma	6.46e-07	0.000876	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NTRK2—glaucoma	6.44e-07	0.000874	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NTRK2—glaucoma	6.37e-07	0.000865	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NGF—glaucoma	6.08e-07	0.000825	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—C3—glaucoma	5.78e-07	0.000784	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NGFR—glaucoma	5.54e-07	0.000752	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NGFR—glaucoma	5.52e-07	0.00075	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GSTM1—glaucoma	5.49e-07	0.000744	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NGFR—glaucoma	5.47e-07	0.000742	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOE—glaucoma	5.38e-07	0.00073	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CAV1—glaucoma	5.33e-07	0.000723	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NTRK1—glaucoma	5.26e-07	0.000714	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NTRK1—glaucoma	5.25e-07	0.000712	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NTRK1—glaucoma	5.2e-07	0.000705	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FN1—glaucoma	5.07e-07	0.000688	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—BAD—glaucoma	5.01e-07	0.00068	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CDKN2B—glaucoma	4.85e-07	0.000658	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MTHFR—glaucoma	4.85e-07	0.000658	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CDKN2B—glaucoma	4.84e-07	0.000656	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CDKN2B—glaucoma	4.79e-07	0.00065	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EDN1—glaucoma	4.65e-07	0.000632	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EDN1—glaucoma	4.64e-07	0.00063	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EDN1—glaucoma	4.59e-07	0.000624	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—glaucoma	4.51e-07	0.000613	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CAV1—glaucoma	4.47e-07	0.000607	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NGF—glaucoma	4.28e-07	0.000581	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NGF—glaucoma	4.26e-07	0.000579	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NGF—glaucoma	4.22e-07	0.000573	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—C3—glaucoma	4.07e-07	0.000552	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—C3—glaucoma	4.05e-07	0.00055	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOS3—glaucoma	4.03e-07	0.000547	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—C3—glaucoma	4.01e-07	0.000545	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—glaucoma	3.79e-07	0.000514	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—glaucoma	3.77e-07	0.000512	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CAV1—glaucoma	3.75e-07	0.000509	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CAV1—glaucoma	3.74e-07	0.000507	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—glaucoma	3.74e-07	0.000507	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CAV1—glaucoma	3.7e-07	0.000503	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FN1—glaucoma	3.57e-07	0.000485	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FN1—glaucoma	3.56e-07	0.000483	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BAD—glaucoma	3.53e-07	0.000479	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FN1—glaucoma	3.52e-07	0.000478	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BAD—glaucoma	3.52e-07	0.000477	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CDKN1B—glaucoma	3.49e-07	0.000474	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BAD—glaucoma	3.48e-07	0.000473	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NOS3—glaucoma	3.38e-07	0.000459	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—glaucoma	3.23e-07	0.000439	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—glaucoma	3.09e-07	0.00042	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—glaucoma	2.9e-07	0.000394	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOS3—glaucoma	2.84e-07	0.000385	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOS3—glaucoma	2.83e-07	0.000384	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOS3—glaucoma	2.8e-07	0.00038	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CDKN1B—glaucoma	2.46e-07	0.000333	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CDKN1B—glaucoma	2.45e-07	0.000332	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CDKN1B—glaucoma	2.43e-07	0.000329	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—glaucoma	2.28e-07	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—glaucoma	2.27e-07	0.000308	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—glaucoma	2.25e-07	0.000305	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TP53—glaucoma	2.19e-07	0.000298	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—glaucoma	2.04e-07	0.000277	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—glaucoma	2.04e-07	0.000276	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—glaucoma	2.02e-07	0.000274	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TP53—glaucoma	1.54e-07	0.00021	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TP53—glaucoma	1.54e-07	0.000209	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TP53—glaucoma	1.52e-07	0.000207	CbGpPWpGaD
